Skip to main content
John Sharretts, MD, Endocrinology, Philadelphia, PA, Philadelphia Veterans Affairs Medical Center

JohnMSharrettsMD

Endocrinology Philadelphia, PA

Diabetes, Lipid Metabolism

Assistant Professor, Medicine, Perelman School of Medicine

Are you Dr. Sharretts?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 57 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. John Sharretts, MD is an endocrinologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Maryland, and District of Columbia. He is affiliated with Philadelphia Veterans Affairs Medical Center and is an Assistant Professor at Perelman School of Medicine.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2008 - 2011
  • MedStar Health/Georgetown-Washington Hospital Center
    MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 1995 - 1999
  • Greater Baltimore Medical Center
    Greater Baltimore Medical CenterInternship, Transitional Year, 1994 - 1995
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 1994

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2011 - 2014
  • MD State Medical License
    MD State Medical License 1999 - 2015
  • DC State Medical License
    DC State Medical License 1997 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

Press Mentions

  • Fish-Oil Medication Approved to Reduce Risk of Cardiovascular Deaths
    Fish-Oil Medication Approved to Reduce Risk of Cardiovascular DeathsDecember 16th, 2019
  • FDA Gives Expanded Approval to Prescription Fish Oil, Vascepa, for Heart Patients
    FDA Gives Expanded Approval to Prescription Fish Oil, Vascepa, for Heart PatientsDecember 16th, 2019
  • FDA Approves Use of Drug to Reduce Risk of Cardiovascular Events in Certain Adult Patient Groups
    FDA Approves Use of Drug to Reduce Risk of Cardiovascular Events in Certain Adult Patient GroupsDecember 16th, 2019
  • Join now to see all

Hospital Affiliations